| abstract |
The present invention relates to a method for treating and / or preventing an immune-related disease selected from the group comprising Type 1 allergy, Type 2 allergy, Type 3 allergy and Type 4 allergy, in a mammal, said method comprising administering to said mammal a composition comprising a therapeutically effective amount of acidic oligosaccharide and neutral oligosaccharide, wherein: acidic oligosaccharide and neutral oligosaccharides have a degree of polymerization between 1 and 250 and are prepared from pectin and alginate, and the neutral oligosaccharides wherein the neutral oligosaccharide is selected from the group consisting of fructans, fructo-oligosaccharides, unsaturated oak , wood oligosaccharides, arabino oligosaccharides, glyco-oligosaccharides, mano-oligosaccharides, fuco-oligosaccharides and mixtures thereof. |